Levity vs NowPatient
NowPatient costs $130 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Levity and NowPatient, the first difference is cost: NowPatient is $130 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Levity leads our six-part score, 7.2 to 6.1. One of the two has an FDA warning letter on record, covered below.
Levity vs NowPatient price
NowPatient is the cheaper way in: $1,069 a month against $1,199 a month at Levity. That is $130 less each month (11% lower), or about $1,560 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Levity ($1,199 a month vs $1,349 a month); tirzepatide is cheaper at NowPatient ($1,069 a month vs $1,299 a month).
Medications and formats
Both sell semaglutide and tirzepatide; only NowPatient lists liraglutide.
On format they match: each offers brand-name pens.
Where each one treats patients
Levity lists 36 states, and NowPatient does not publish where it ships.
Pricing
Levity
NowPatient
What each price covers
Both prices cover the clinician visit and the medication itself.
Levity's price also covers shipping, which NowPatient does not claim.
Levity is silent on lab work and coaching.
NowPatient is silent on shipping, lab work and coaching.
Levity
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
NowPatient
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Levity scores 7.2 and NowPatient 6.1 out of 10.
Levity is stronger on user experience (8.0 vs 2.5), trust & safety (5.5 vs 4.0), accessibility (7.8 vs 5.0) and support (7.0 vs 5.5).
NowPatient is stronger on value (6.1 vs 4.7).
Effectiveness is within half a point.
Levity
7.2/10
NowPatient
6.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Levity a warning letter dated February 20, 2026 (letter 717990), and it is still open.
NowPatient has no FDA warning letter on record with us.
Features & Coverage
| Feature | Levity | NowPatient |
|---|---|---|
| Starting Price | $1,199/mo | ✓$1,069/mo |
| Features | ✓8 features | 2 features |
| States Available | 36 | Not disclosed |
| Compounded | — | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Levity
Expect between 1,199 and 1,599 dollars a month once the first-month discount falls away, the exact figure depending on which drug. That single monthly fee absorbs the prescription, the consultation, delivery, follow-up care and clinical support without limit. No compounded GLP-1 is dispensed. Levity carries only FDA-approved branded products, Mounjaro (tirzepatide), Wegovy (semaglutide) and Ozempic (semaglutide), each a weekly injectable pen. A LegitScript badge is displayed and both pharmacy and physician leaders are named. It operates in 34 states, with progress tracking.
Read our full Levity review →About NowPatient
Nothing is charged for the consultation at NowPatient; the medication is the whole bill. Because the out-of-pocket cost tracks brand list prices, an uninsured patient faces roughly $1,000-$1,350/mo. Access is to brand-name GLP-1s for weight management: Saxenda is on the menu, so is Mounjaro, and Wegovy comes as an injection and as an oral tablet. The company spans the US and UK, HQ Austin, TX.
Read our full NowPatient review →Pros & Cons
Levity
What we like
- Tirzepatide costs $1299 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- Semaglutide costs $1199 a month, 20% above the $997 median for brand-name semaglutide across the sellers we compare
- Serves only 36 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Levity a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
NowPatient
What we like
- Tirzepatide costs $1069 a month, 14% below the $1249 median for brand-name tirzepatide across the sellers we compare
- The monthly price includes the medication and clinician visits
- We found no FDA warning letters issued to NowPatient
- A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
Watch-outs
- Semaglutide costs $1349 a month, 35% above the $997 median for brand-name semaglutide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Levity wins this one, 7.2 to 6.1, above all for semaglutide from $1199/month. NowPatient undercuts it by $130 a month, so if the monthly bill is what decides it, NowPatient is the pick. NowPatient fits better if an oral route if you will not self-inject is your priority.
Choose Levity if…
You want semaglutide from $1199/month and an opening price near $1,199 a month.
Choose NowPatient if…
You want an oral route if you will not self-inject and an opening price near $1,069 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
RxSpan MD
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $249/mo
Get started →Luvo Health
Moving between compounded and brand without changing seller
From $249/mo
Get started →Strut Health
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Levity vs NowPatient: FAQ
Close alternatives to Levity and NowPatient
- Levity vs Form Health
- Levity vs myRocky
- Levity vs TrimRx
- Levity vs Klinic
- NowPatient vs Alloy
- NowPatient vs Form Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.